Member Info for Pingu777

20x current SP to get back a holding bought 5yrs ago (95% down). Current mcap £6m meaning £120m for parity. Without a shadow of a doubt, if CAR T is as good as is indicated, then you'd be very disappointed if we didn't at least double that target.

The share price is a tough one to figure. But these anomalies are what make people rich who buy at the bottom. Would've be nice if someone gave a more formal clue of where the bottom will be SP-wise. Lol

Petepharma

Because he has 100% exposure through his warrants now. And wanted as much cash back as possible. Liquidity is king. Lets say he lost 30% net on his capital retaining 70% of his cash. For that 30% loss he gets 10)% exposure through the warrants.

Its not complicated.

*patient 1

The story I was told was that the 40% discount placing was due to a late demand from the placee which was very unexpected and lower than HEMO hoped. The surrounding 3 placings were at SP or higher so it was indeed an outlier.

If warrants are attached (as seems standard now), I'd hope a serious discount is not necessary at this point. And I'm very much encouraged by the expenditure reductions which seem to be substantial and should a significant impact on making cash last as patient results are accumulated.

If HG-CT-1 has curative indications then quite obviously any sort of generalised metric of value goes out of the window. 6 months patient 2 data could light fireworks.

$15m would be nice Hulver!

The City appetite for placings in the UK seems at an all time low across the full spectrum of junior pharma. However, it's not that sort of funding that peaks my interest. We have multiple other potential sources of income that must be on the table now.

P1 and P2 data is mounting - irrespective of anything else!

I'm confident its the last placee selling up the final portion of their holding and taking a loss overall.

And if I'm correct there shouldn't be too much holding this down then. A big old sell order lodged that all the dark forces seem to know is in play!

My deductions exactly

Two years?

Good luck mate. I can't see anything other than large profits from buying at these levels.

But my point with this sort of shorting activity going on is that you can't trust posters on here with their "I'm just adding some balance" to the thread that seems to be intentionally FUDing. It usually is what it looks like. Occam's Razor and all that. They'll be selling down to short or buy cheaper.

Lets be fair, we've seen it all before!

Multiple transactions of fixed blocks of selling looks more like shorting to me. Deliberate SP reduction to increase any forthcoming dilution.

But what do I know 🤷

🥱

Stuuuuuuu…….

Never stop.l being you.

Efficacy PLUS safety… have you seen it anywhere else? In combination in a CAR T? Send us the links.

Thanks.

Micky

I’ve just read your last 50 messages. (It was painful)

No way on earth you’re a real investor though. You’re relentless. You’re so expressively negative it’s blatantly obvious you have no interest in HEMOs SP going up in value.

Just thought I’d mention it.

Although a CAR T licensing/JV/Partnership deal is what we want for the upfront cash, I'm pretty sure HEMO will be attempting to utilise many more potential sources of income to keep the ball rolling.

Let there be no doubt, we have an advanced asset to collateralise right now. We also have multiple other assets.

Vlad could very quickly switch from villain to hero.

Staying very positive.

Checking in here is funny.

Zero tolerance for an end game. Zero understanding of the incredible asset. Zero patience.

So many people invested with zero clue about why they did. 😂

I want more than that.

Pumpky

It is possible, nay part of the trial protocol, to make durability projections based on current data.

You insufferable degenerate.

It takes some minerals to suggest a milestoned billion dollar big pharma JV deal would the equivalent of a “jam tomorrow” analogy 😂

Keep it up Stu. Friday afternoon chuckles.

*will be interested

HG CT 1 and CDX complement each other.

Any pharma interested in HG CT 1 will I’ve interested in CDX too.

How saleable is HEMO now? How much debt do we have?